Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Therapeutic Drug Monitoring

• Publication date

  2004-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/00007691-200404000-00023PMID 15228168
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C2 Monitoring Strategy for Optimising Cyclosporin Immunosuppression from the Neoral® Formulation

  2012cited by this paper
• BY LIQUID CHROMATOGRAPHY – MASS SPECTROMETRY

  2004cited by this paper
• Liquid chromatography/mass spectrometry for therapeutic drug monitoring of immunosuppressants

  2003cited by this paper
• Ion suppression in mass spectrometry.

  2003cited by this paper
• Measurement of free drug and clinical end-point by high-performance liquid chromatography-mass spectrometry: Applications and implications for pharmacokinetic and pharmacodynamic studies

  2003cited by this paper
• Quantification and stability of everolimus (SDZ RAD) in human blood by high-performance liquid chromatography-electrospray tandem mass spectrometry.

  2002cited by this paper
• Simultaneous and Rapid Analysis of Cyclosporin A and Creatinine in Finger Prick Blood Samples Using Liquid Chromatography Tandem Mass Spectrometry and Its Application in C2 Monitoring

  2002cited by this paper
• Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood.

  2002cited by this paper
• Rapid liquid chromatography-tandem mass spectrometry method for routine analysis of cyclosporin A over an extended concentration range.

  2002cited by this paper
• Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range.

  2002cited by this paper
• Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.

  2002cited by this paper
• Quantification of Sirolimus by Liquid Chromatography-Tandem Mass Spectrometry Using On-Line Solid-Phase Extraction

  2002cited by this paper
• International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology Working Group on Immunosuppressive Drug Monitoring

  2002influential reference
• Therapeutic drug monitoring of immunosuppressive drugs in kidney transplantation

  2002cited by this paper
• Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry

  2002cited by this paper
• Simultaneous Quantification of Sirolimus, Everolimus, Tacrolimus and Cyclosporine by Liquid Chromatography-Mass Spectrometry (LC-MS)

  2002cited by this paper
• Strategies to Reduce Toxicities and Improve Outcomes in Renal Transplant Recipients

  2002cited by this paper
• High-throughput semi-automated 96-well liquid/liquid extraction and liquid chromatography/mass spectrometric analysis of everolimus (RAD 001) and cyclosporin a (CsA) in whole blood.

  2001cited by this paper
• Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies

  2001cited by this paper
• Therapeutic Monitoring of Tacrolimus Concentrations in Blood: Semi-Automated Extraction and Liquid Chromatography-Electrospray Ionization Mass Spectrometry

  2001cited by this paper
• Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography--tandem mass-spectrometry.

  2001cited by this paper
• New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine.

  2001cited by this paper
• Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants.

  2000cited by this paper
• The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients.

  2000cited by this paper
• Sirolimus-tacrolimus combination immunosuppression.

  2000cited by this paper
• Ternary-column system for high-throughput direct-injection bioanalysis by liquid chromatography/tandem mass spectrometry.

  2000cited by this paper
• New approaches to cyclosporine monitoring raise further concerns about analytical techniques.

  2000cited by this paper
• Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection.

  2000cited by this paper
• High-throughput analysis of everolimus (RAD001) and cyclosporin A (CsA) in whole blood by liquid chromatography/mass spectrometry using a semi-automated 96-well solid-phase extraction system.

  2000cited by this paper
• Quantification of free mycophenolic acid by high-performance liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry.

  2000cited by this paper
• Liquid chromatography-mass spectrometry in the study of the metabolism of drugs and other xenobiotics.

  2000cited by this paper
• Simultaneous Quantification of Tacrolimus and Sirolimus, in Human Blood, by High-Performance Liquid Chromatography–Tandem Mass Spectrometry

  2000cited by this paper
• Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.

  1999cited by this paper
• Current opinions on therapeutic drug monitoring of immunosuppressive drugs.

  1999cited by this paper
• Atmospheric pressure ionization LC/MS/MS techniques for drug disposition studies.

  1998cited by this paper
• Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin.

  1998cited by this paper
• Microscale high-performance liquid chromatography-electrospray tandem mass spectrometry assay for cyclosporin A in blood.

  1998cited by this paper
• Automated simultaneous quantification of the immunosuppressants 40-O-(2-hydroxyethyl) rapamycin and cyclosporine in blood with electrospray-mass spectrometric detection.

  1998cited by this paper
• SDZ RAD, a new rapamycin derivative: synergism with cyclosporine.

  1997cited by this paper
• Electrospray: Principles and Practice

  1997cited by this paper
• Pitfalls in monitoring tacrolimus (FK 506).

  1997cited by this paper
• Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat.

  1997cited by this paper
• Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection

  1997cited by this paper
• A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry.

  1997cited by this paper
• An HPLC/MS/MS assay for tacrolimus in patient blood samples. Correlation with results of an ELISA assay.

  1997cited by this paper
• Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry.

  1996cited by this paper
• Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry.

  1996cited by this paper
• Simplified High‐Performance Liquid Chromatography‐Mass Spectrometry Assay for Measurement of Tacrolimus and Its Metabolites and Cross‐Validation with Microparticle Enzyme Immunoassay

  1995cited by this paper
• Lake Louise Consensus Conference on Cyclosporin Monitoring in Organ Transplantation: Report of the Consensus Panel

  1995cited by this paper
• The emergence of mass spectrometry in biochemical research.

  1994cited by this paper
• Recent Advances in High‐Performance Liquid Chromatography/Mass Spectrometry and High‐Performance Liquid Chromatography/Tandem Mass Spectrometry: Detection of Cyclosporine and Metabolites in Kidney and Liver Tissue

  1993cited by this paper
• Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine.

  1990cited by this paper
• Ion spray interface for combined liquid chromatography/atmospheric pressure ionization mass spectrometry

  1987cited by this paper
• High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samples.

  1986cited by this paper

• The Effect of Polymerization Techniques on the Creation of Molecularly Imprinted Polymer Sensors and Their Application on Pharmaceutical Compounds

  2024cites this paper
• Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.

  2024cites this paper
• Is the automated Elecsys tacrolimus assay on the Roche cobas e 602 analyzer an acceptable replacement for a liquid chromatography-tandem mass spectrometry-based assay?

  2023cites this paper
• Molecularly imprinted polymer-modified carbon paste electrodes (MIP-CPE): A review on sensitive electrochemical sensors for pharmaceutical determinations

  2023cites this paper
• Mass spectrometry quantitation of immunosuppressive drugs in clinical specimens using online solid-phase extraction and accurate-mass full scan-single ion monitoring

  2023cites this paper
• Whole-genome resequencing to unveil genetic characteristics and selection signatures of specific pathogen-free ducks

  2023cites this paper
• Dried blood microsampling-assisted therapeutic drug monitoring of immunosuppressants: An overview.

  2022cites this paper
• Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomalies

  2022cites this paper
• Immunosuppressant Monitoring—Performance of the First Mass Spectrometry–Based Automated Clinical Analyzer Cascadion

  2022cites this paper
• Erratum: Recommendations for the Use of Liquid Chromatography-Mass Spectrometry in the Clinical Laboratory: Part I. Implementation and Management

  2020cites this paper
• Recommendations for the Use of Liquid Chromatography-Mass Spectrometry in the Clinical Laboratory: Part I. Implementation and Management

  2020cites this paper
• Therapeutic drug monitoring of immunosuppressants

  2020cites this paper
• Issues of interferences in therapeutic drug monitoring

  2019cites this paper
• High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss

  2019cites this paper
• Antineoplastic drugs and their analysis: a state of the art review.

  2017cites this paper
• Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service.

  2016cites this paper
• Therapeutic Drug Monitoring in Infants and Children

  2016cites this paper
• The emerging role of multiplex tandem mass spectrometry analysis for therapeutic drug monitoring and personalized medicine

  2016cites this paper
• Therapeutic Drug Monitoring of Everolimus: A Consensus Report

  2016cites this paper
• The influence of the sample matrix on LC-MS/MS method development and analytical performance

  2015cites this paper
• [Some thoughts on the links between LC-MS/MS and therapeutic drug monitoring].

  2015cites this paper
• Sample Cleanup Using Solid-Phase Dispersive Extraction for Determination of Vancomycin in Serum

  2014cites this paper
• A candidate reference measurement procedure for Cyclosporine A in whole blood

  2014cites this paper
• Liquid chromatography-tandem mass spectrometry method as the golden standard for therapeutic drug monitoring in renal transplant.

  2013cites this paper
• Comparison between ultra-performance liquid chromatography with tandem mass spectrometry and a chemiluminescence immunoassay in the determination of cyclosporin A and tacrolimus levels in whole blood

  2013cites this paper
• Improved Method for Therapeutic Drug Monitoring of 6-Thioguanine Nucleotides and 6-Methylmercaptopurine in Whole-Blood by LC/MSMS Using Isotope-Labeled Internal Standards

  2013cites this paper
• Simultaneous determination of cyclosporine, sirolimus, and tacrolimus in whole blood using liquid chromatography-tandem mass spectrometry.

  2012cites this paper
• Drug interaction between tacrolimus and ertapenem in renal transplantation recipients.

  2012cites this paper
• Determination of four immunosuppressive drugs in whole blood using MEPS and LC-MS/MS allowing automated sample work-up and analysis.

  2012cites this paper
• Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era.

  2012cites this paper
• Immunosuppressive Drug Monitoring: Limitations of Immunoassays and the Application of Liquid Chromatography Mass Spectrometry

  2012cites this paper
• Therapeutic Drug Monitoring of Immunosuppressants: Limitations of Immunoassays and the Need for Chromatographic Methods

  2012cites this paper
• Therapeutic Drug Monitoring (TDM) in Renal Transplant (RT): Reasons to Choose the LC-MS/MS Method

  2012cites this paper
• Therapeutic Drugs and Their Management

  2012cites this paper
• Applications of LC‐MS/MS in Clinical Laboratory Diagnostics

  2012cites this paper
• Chromatography Separation Techniques Therapeutic Drug Monitoring ( TDM ) in Renal Transplant ( RT ) : Reasons to Choose the LC-MS / MS Method

  2012cites this paper
• Therapeutic drug monitoring of tacrolimus by liquid chromatography-tandem mass spectrometry: is it truly a routine test?

  2012cites this paper
• Successful and cost-efficient replacement of immunoassays by tandem mass spectrometry for the quantification of immunosuppressants in the clinical laboratory.

  2012cites this paper
• THERAPEUTIC DRUG MONITORING OF TACROLIMUS AND CYCLOSPORINE, PHENYTOIN A ND VALPROIC ACID

  2012cites this paper
• Evaluation of the MassTrak Immunosuppressant XE Kit for the determination of everolimus and cyclosporin A in human whole blood employing isotopically labeled internal standards

  2011cites this paper
• The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs.

  2011cites this paper
• Mass spectrometry for clinical toxicology: therapeutic drug management and trace element analysis.

  2011cites this paper
• High throughput automated LC-MS/MS analysis of endogenous small molecule biomarkers.

  2011cites this paper
• Liquid chromatography-tandem mass spectrometry method for simultaneous determination of cyclosporine A and its three metabolites AM1, AM9 and AM4N in whole blood and isolated lymphocytes in renal transplant patients.

  2010cites this paper
• Challenges in mass spectrometry based targeted metabolomics.

  2010cites this paper
• LC-MS/MS for immunosuppressant therapeutic drug monitoring.

  2010cites this paper
• Multi-center evaluation of a commercial Kit for tacrolimus determination by LC/MS/MS.

  2010cites this paper
• Does liquid chromatography-tandem mass spectrometry have a role in therapeutic drug monitoring of digoxin?

  2010cites this paper
• Steroid measurement with LC-MS/MS in pediatric endocrinology.

  2009cites this paper
• Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry.

  2009cites this paper
• Validation of a Liquid Chromatography-Mass Spectrometric Assay for Tacrolimus in Peripheral Blood Mononuclear Cells

  2009cites this paper
• Robust, High-Throughput LC-MS/MS Method for Therapeutic Drug Monitoring of Cyclosporine, Tacrolimus, Everolimus, and Sirolimus in Whole Blood

  2009cites this paper
• Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.

  2008cites this paper
• A High-Performance Liquid Chromatography-Mass Spectrometry Method Using a Novel Atmospheric Pressure Chemical Ionization Approach for the Rapid Simultaneous Measurement of Tacrolimus and Cyclosporin in Whole Blood

  2008cites this paper
• Comparison of the CEDIA and MEIA assays for measurement of tacrolimus in organ transplant recipients.

  2008cites this paper
• Analytical Techniques for Measuring Concentrations of Therapeutic Drugs in Biological Fluids

  2008cites this paper
• Heparinized blood provides equivalent results to EDTA in the CEDIA and FPIA cyclosporine immunoassays, thus facilitating routine cyclosporine determination.

  2008cites this paper
• Immunosuppressive Drugs: Pharmacokinetics, Preanalytic Variables, and Analytical Considerations

  2008cites this paper
• Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation.

  2007cites this paper
• Therapeutic drug monitoring of immunosuppressants: An overview

  2007cites this paper
• Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure.

  2007cites this paper
• Current role of LC-MS in therapeutic drug monitoring

  2007cites this paper
• Comparison of the CEDIA and MEIA assays for the measurement of sirolimus in organ transplant recipients.

  2007cites this paper
• 6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.

  2007cites this paper
• Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection.

  2006cites this paper
• Measurement and stability of FTY720 in human whole blood by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.

  2006cites this paper
• Simultaneous determination of three isomeric metabolites of tacrolimus (FK506) in human whole blood and plasma using high performance liquid chromatography-tandem mass spectrometry.

  2006cites this paper
• Managing arthritis and vascular disease - a rheumatology perspective

  2006cites this paper
• Simultaneous quantitative determination of cyclosporine A and its three main metabolites (AM1, AM4N and AM9) in human blood by liquid chromatography/mass spectrometry using a rapid sample processing method.

  2006cites this paper
• Application of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 high volume clinical chemistry analyzer.

  2006cites this paper
• Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan

  2006cites this paper
• Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population.

  2006cites this paper
• Experimental and clinical pharmacology Immunosuppressants - mechanisms of action and monitoring

  2006cites this paper
• Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.

  2006cites this paper
• Comparative Bioavailability of the Microemulsion Formulation of Cyclosporine (Neoral) With a Generic Dispersion Formulation (Cicloral) in Young Healthy Male Volunteers

  2006cites this paper
• Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients.

  2006cites this paper
• The nucleotide derivatives inosine and inosinic acid inhibit intestinal absorption of mizoribine in rats.

  2006cites this paper
• Automated processing of whole blood samples for the determination of immunosuppressants by liquid chromatography tandem-mass spectrometry

  2006cites this paper
• Current literature in mass spectrometry.

  2005cites this paper
• Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry.

  2005cites this paper
• High-Performance Liquid Chromatography-Mass Spectrometry in the Clinical Laboratory

  2005cites this paper
• Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.

  2005cites this paper
• Determination of rapamycin: quantification of the sodiated species by an ion trap mass spectrometer as an alternative to the ammoniated complex analysis by triple quadrupole.

  2005cites this paper
• A rapid HPLC-mass spectrometry cyclosporin method suitable for current monitoring practices.

  2005cites this paper
• Rapid, long-range molecular haplotyping of thiopurine S-methyltransferase (TPMT) *3A, *3B, and *3C.

  2004cites this paper
• Rapid detection of ITPA 94C>A and IVS2 + 21A>C gene mutations by real-time fluorescence PCR and in vitro demonstration of effect of ITPA IVS2 + 21A>C polymorphism on splicing efficiency.

  2004cites this paper